Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation

Oncolytic herpes virus armed with vasculostatin in combination with bevacizumab abrogate glioma invasion via the CCN1 and AKT signaling pathways

(2019) Yusuke Tomita et al.   MOLECULAR CANCER THERAPEUTICS

oHSV therapy increases trametinib access to brain tumors and sensitizes them in vivo

(2019) Ji Young Yoo et al.   NEURO-ONCOLOGY

Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment

(2019) Heidi Harjunpää et al.   Frontiers in Immunology

Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study

(2018) Baorang Zhu et al.   CANCER BIOLOGY & THERAPY

Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?

(2018) Luke D. Rothermel et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer

(2018) Maria Georganaki et al.   Frontiers in Immunology

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema

(2018) Bangxing Hong et al.   Molecular Therapy-Oncolytics

Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma

(2017) Neel P. Chudgar et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Review: Oncolytic virotherapy, updates and future directions

(2017) Christos Fountzilas et al.   Oncotarget

Targeting angiogenesis in advanced soft tissue sarcoma: Tivozanib - hype or me-too ?

(2016) O. Mir et al.   ANNALS OF ONCOLOGY

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

(2016) Chelsea Bolyard et al.   CLINICAL CANCER RESEARCH

Oncolytic herpes simplex virus interactions with the host immune system

(2016) Dipongkor Saha et al.   Current Opinion in Virology

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses

(2016) Guy Ungerechts et al.   Molecular Therapy-Methods & Clinical Development

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma

(2015) Ji Young Yoo et al.   Molecular Therapy-Oncolytics

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

(2015) Gonzalo Lopez et al.   PLoS One

The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets

(2014) Laura Rocchi et al.   BIOSCIENCE REPORTS

Targeted therapy in sarcomas other than GIST tumors

(2014) Douglas Sborov et al.   JOURNAL OF SURGICAL ONCOLOGY

Vascular remodeling in cancer

(2013) R H Farnsworth et al.   ONCOGENE

Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-expressing Oncolytic Virus

(2011) Ji Young Yoo et al.   MOLECULAR THERAPY

Impact of tumor microenvironment on oncolytic viral therapy

(2010) Jeffrey Wojton et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

(2010) Lucia Ricci-Vitiani et al.   NATURE

Endotoxin-Induced Myeloid-Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase-1

(2009) V. De Wilde et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism

(2009) B. Kaur et al.   CANCER RESEARCH

Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1

(2009) Jayson Hardcastle et al.   MOLECULAR THERAPY

Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61

(2008) Kazuhiko Kurozumi et al.   MOLECULAR THERAPY